100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.
Watch the full video: bit.ly/100-percent-ca…
@VigilantFox This is truly a breakthrough. What a hopeful thing to see in these difficult times. ❤️
They plan to make money off the Covid vaccine injured. Autoimmune diseases, blood clots, heart injuries, neurological injuries are still happening because of the “vaccines”. What all the big vaccine companies are positioning themselves in is cancer. Johnson & Johnson just completed a $2 Billion acquisition of a cancer company. Bio Tech came out and said that our revenue is down the toilet because nobody wants the covid vaccines anymore, but by 2025 we will position in the Oncology space to make money on cancer. They are all positioning
@VigilantFox @ScottAdamsSays 🚨 Rectal Cancer Remission Study! 🚨
@VigilantFox Someday, cancer will be less serious than the common cold & flu
@VigilantFox What's the catch? I don't trust any of them. Especially hearing they are using monoclonal antibodies.